Biblio
.
Impact of high molecular risk mutations on transplant outcomes in patients with myelofibrosis. Biol Blood Marrow Transplant. 2019.
Role of epigenetic reprogramming in hematopoietic stem cell function. Curr Opin Hematol. 2015;22(4):279-285.
.